NTRA

Natera, Inc.

109.97 USD
+0.15 (+0.14%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Natera, Inc. stock is up 18.4% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 77.78% of the previous 8 May’s closed higher than April. In the last 10 Unusual Options Trades, there were 6 PUTs, 4 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
09 May 15:26 17 May, 2024 92.50 PUT 70 380
09 May 17:36 17 May, 2024 105.00 CALL 723 1456
10 May 13:32 21 Jun, 2024 115.00 CALL 100 0
10 May 13:32 21 Jun, 2024 115.00 CALL 100 0
20 May 17:57 17 Jan, 2025 115.00 CALL 20 0
21 May 17:49 18 Oct, 2024 105.00 PUT 30 5
21 May 18:06 18 Oct, 2024 110.00 PUT 30 4
29 May 17:40 20 Sep, 2024 110.00 PUT 25 1
29 May 18:48 20 Sep, 2024 105.00 PUT 43 0
29 May 18:51 20 Sep, 2024 105.00 PUT 32 0

About Natera, Inc.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage.

  • Piper Sandler
    Tue May 14, 07:53
    buy
    confirm
  • BTIG
    Mon May 13, 10:35
    buy
    confirm
  • Canaccord Genuity
    Fri May 10, 14:29
    buy
    confirm
  • TD Cowen
    Fri May 10, 13:34
    buy
    confirm
  • Baird
    Fri May 10, 07:22
    buy
    confirm